Readmission among hospitalized patients with nonvalvular atrial fibrillation

American Journal of Health-System Pharmacy

Volumn 70, Issue 5, 2013, Pages 414-422

  Johnson, Barbara H ^a   Smoyer Tomic, Karen E ^b   Siu, Kimberly ^c   Walker, David R ^d   Sander, Stephen ^d   Huse, Dan ^e   Smith, David M ^a   Song, Xue ^a   Amin, Alpesh ^f  

^a IBM WATSON HEALTH   (United States)

^b OXFORD PHARMAGENESIS LTD   (United Kingdom)

^c Clinical Development and Medical Affairs Abbott   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e Analytical Consulting and Research Services   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CLINICAL STUDY; DEMOGRAPHY; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; ISCHEMIC HEART DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONVALVULAR ATRIAL FIBRILLATION; PRESCRIPTION; PRIORITY JOURNAL; SELF CARE; SYMPTOM;

EID: 84874089821     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp120461     Document Type: Article

References (27)

1. Naccarelli GV, Varker H, Lin J et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009; 104:1534-9.
2. Kim MH, Johnston SS, Chu BC et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes. 2011; 4:313-20.
3. Ruskin JN, Singh J P. Atrial fibrillation endpoints: hospitalization. Heart Rhythm. 2004; 1(suppl 2):B31-5.
4. Wu EQ, Birnbaum HG, Mareva M et al. Economic burden and co-morbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin. 2005; 21:1693-9.
5. Mercaldi CJ, Ciarametaro M, Hahn B et al. Cost efficiency of anticoagulation with warfarin to prevent stroke in Medicare beneficiaries with nonvalvular atrial fibrillation. Stroke. 2011; 42:112-8.
6. Kim MH, Lin J, Hussein M et al. Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation. Curr Med Res Opin. 2009; 25:1215-20.
7. Stauffer BD, Fullerton C, Fleming N et al. Effectiveness and cost of a transitional care program for heart failure: a prospective study with concurrent controls. Arch Intern Med. 2011; 171:1238-43.
8. ScienceDaily. Studies evaluate programs to transition care of patients after hospital discharge. www.sciencedaily.com/releases/2011/07/110725190035.htm (accessed 2011 Aug 30).
9. Agency for Healthcare Research and Quality. Implementing re-engineered hospital discharges (project RED). www.ahrq.gov/news/kt/red (accessed 2011 Aug 30).
10. Project RED (Re-Engineered Discharge). http://bu.edu/fammed/projectred/ index.html (accessed 2011 Aug 30).
11. Jack BW, Chetty VK, Anthony D et al. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. 2009; 150:178-87.
12. The Care Transitions Program. www.care-transitions.org (accessed 2011 Aug 30).
13. Voss R, Gardner R, Baier R et al. The care transitions intervention: translating from efficacy to effectiveness. Arch Intern Med. 2011; 171:1232-7.
14. Project BOOST, Better Outcomes for Older Adults Through Safe Transitions. http://hospitalmedicine.org/BOOST (accessed 2011 Aug 30).
15. American College of Cardiology. H2H, Hospital to Home, Reducing Readmissions, Improving Transitions. www.h2hquality.org (accessed 2011 Aug 30).
16. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45:613-9.
17. Gage BF, Waterman AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285:2864-70.
18. Epstein AM, Jha AK, Orav EJ. The relationship between hospital admission rates and rehospitalizations. N Engl J Med. 2011; 365:2287-95.
19. Hammill BG, Curtis LH, Fonarow GC et al. Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization. Circ Cardiovasc Qual Outcomes. 2011; 4:60-7.
20. Keenan PS, Normand SL, Lin Z et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008; 1:29-37.
21. Amarasingham R, Moore BJ, Tabak YP et al. An automated model to identify heart failure patients at risk for 30-day read-mission or death using electronic medical record data. Med Care. 2010; 48:981-8.
22. Ruskin JN, Singh JP. Atrial fibrillation endpoints: hospitalization. Heart Rhythm. 2004; 1(suppl 2):B31-4, discussion B34-5.
23. Vest JR, Gamm LD, Oxford BA et al. Determinants of preventable readmissions in the United States: a systematic review. Implement Sci. 2010; 5:88.
24. Hansen LO, Young RS, Hinami K et al. Interventions to reduce 30-day rehospi-talization: a systematic review. Ann Intern Med. 2011; 155:520-8.
25. Novak CJ, Hastanan S, Moradi M et al. Reducing unnecessary hospital readmissions: the pharmacist's role in care transitions. Consult Pharm. 2012; 27:174-9.
26. Bellone JM, Barner JC, Lopez DA. Postdischarge interventions by pharmacists and impact on hospital readmission rates. J Am Pharm Assoc. 2012; 52:358-62.
27. Hernandez AF, Greiner MA, Fonarow GC et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010; 303:1716-22.